Tixagevimab-Cilgavimab: Utilization in the solid organ transplant population

被引:0
|
作者
Shaikh, Suhail A. [1 ]
Morado, Faiza [2 ]
Kawewat-Ho, Pnada [1 ]
Cartus, Rachel [1 ]
Davoudi, Roland [1 ]
Forrester, Kevin [3 ]
Azizian, Krist [3 ]
Blodget, Emily [4 ]
Maw, Thin Thin [4 ]
Nanda, Neha [4 ]
机构
[1] Univ Southern Calif, USC Transplant Inst, Keck Hosp USC, 1516 San Pablo S 32269, Los Angeles, CA 90033 USA
[2] Univ Southern Calif, Dept Clin Pharm, Keck Hosp USC, Los Angeles, CA 90007 USA
[3] Univ Southern Calif, Hlth Sci Ctr, Dept Clin Pharm, Los Angeles, CA 90007 USA
[4] Univ Southern Calif, Dept Med, Keck Med Ctr, Los Angeles, CA USA
关键词
D O I
10.1111/ctr.14661
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Single-Center Review of Tixagevimab-Cilgavimab Use in Solid Organ Transplant Recipients
    Shaikh, S.
    Davoudi, R.
    Kawewat-Ho, P.
    Cartus, R.
    Morado, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S660 - S661
  • [2] A single-center review of pre-exposure prophylaxis with tixagevimab-cilgavimab in solid organ transplant recipients
    Morado, Faiza
    Davoudi, Roland
    Kawewat-Ho, Pnada
    Nanda, Neha
    Cartus, Rachel
    Shaikh, Suhail A.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (04)
  • [3] Tixagevimab-Cilgavimab Decreases the Rate of SARS-CoV-2 Infection Among Solid Organ Transplant Recipients
    Sanayei, Ava M.
    Montalvan, Adriana
    Faria, Isabella
    Ochalla, Julia
    Pavlakis, Martha
    Blair, Barbra M.
    Alonso, Carolyn D.
    Curry, Michael
    Saberi, Behnam
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (08) : 1784 - 1792
  • [4] SARS-CoV-2 Vaccination Rates and Uptake of Tixagevimab-Cilgavimab Among a Cohort of Pediatric Solid Organ Transplant Recipients
    Reis, C.
    Madigan, T.
    Ristagno, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S390 - S390
  • [5] SARS-CoV-2 Vaccination Rates and Uptake of Tixagevimab-Cilgavimab Among a Cohort of Pediatric Solid Organ Transplant Recipients
    Reis, Christopher A.
    Ristagno, Elizabeth H.
    Madigan, Theresa
    CLINICAL TRANSPLANTATION, 2024, 38 (07)
  • [6] Assessing the post hoc effectiveness of tixagevimab-cilgavimab for prevention of SARS-CoV-2 infections in solid organ transplant recipients
    Jordan, Stanley C.
    Joung, Sandy Y.
    Wang, Minhao
    Tran, Teresa Anh
    Bravo, Michelle
    Masoom, Hibah
    Chang, Christine
    Mendez, Marilyn
    Patel, Jignesh
    Sun, Nancy
    Kittleson, Michelle
    Frias, Edwin
    Prostko, John C.
    Ebinger, Joseph E.
    Cheng, Susan
    Sobhani, Kimia
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (01)
  • [7] Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients
    Benotmane, Ilies
    Olagne, Jerome
    Gautier-Vargas, Gabriela
    Cognard, Noelle
    Heibel, Francoise
    Braun-Parvez, Laura
    Keller, Nicolas
    Martzloff, Jonas
    Perrin, Peggy
    Pszczolinski, Romain
    Moulin, Bruno
    Fafi-Kremer, Samira
    Caillard, Sophie
    TRANSPLANTATION, 2023, 107 (08) : E215 - E218
  • [8] Tixagevimab/cilgavimab for the prevention of COVID-19 in solid organ transplant recipients
    Eribes, Emily
    Votruba, Cassandra
    Tinkham, Tyler
    Huang, Angela
    Ilges, Dan
    Kunze, Katie
    Hudson, Madeline
    CLINICAL TRANSPLANTATION, 2024, 38 (02)
  • [9] COVID-19 outcomes in solid organ transplant patients given tixagevimab-cilgavimab prophylaxis and/or bebtelovimab treatment in a nurse-led program
    Cochran, W.
    Alejandre, S. Salto
    Barker, L.
    Freed, K.
    Carter, D.
    Bannon, J.
    Goddard, D.
    Werbel, W.
    Mostafa, H.
    Brennan, D.
    Shah, P.
    Avery, R.
    SWISS MEDICAL WEEKLY, 2022, 152 : 31S - 31S
  • [10] Efficacy of Tixagevimab-Cilgavimab as Immunoprophylaxis in Patients With Hematologic Cancer
    Salvini, Marco
    Grossi, Paolo Antonio
    Cacioppo, Alessandro
    Merli, Michele
    Pellegrini, Giacomo
    Brociner, Marco
    Passamonti, Francesco
    JAMA ONCOLOGY, 2024, 10 (03) : 405 - 407